
Centene (CNC) Stock Forecast & Price Target
Centene (CNC) Analyst Ratings
Bulls say
Centene is expected to see continued growth through its strong presence in government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges, as well as its Medicare Part D pharmaceutical plans. The company's strong 1Q results and raised FY guidance, driven by outperformance in Medicaid and Medicare, demonstrate its solid financial performance and growth potential. Furthermore, its focus on cost management and initiatives to improve medical cost trends further solidify our positive outlook for the stock.
Bears say
Centene is facing near-term challenges in the Marketplace due to market dynamics and potential discrepancies between Medicaid rates and acuity. Additionally, their operating environment for Medicaid and the Marketplace remains difficult to navigate. While they have effective operations, market forces and the potential for lower margins in 2026 and 2027 make it difficult to justify investing in Centene.
This aggregate rating is based on analysts' research of Centene and is not a guaranteed prediction by Public.com or investment advice.
Centene (CNC) Analyst Forecast & Price Prediction
Start investing in Centene (CNC)
Order type
Buy in
Order amount
Est. shares
0 shares